Methyl morpholine oxide → HCID 86672793, compound
Reaction equation
C[N+]1([O-])CCOCC1.[OH:9][CH2:10][CH2:11][CH2:12][CH2:13][CH2:14][CH2:15][CH2:16][CH2:17][CH2:18][C:19]1[NH:23][C:22](=[O:24])[C:21]2([CH2:29][CH2:28][N:27]([S:30]([CH2:33][CH2:34][C:35]3[C:40]([CH3:41])=[CH:39][C:38]([N:42]([CH3:46])[C:43]([NH2:45])=[O:44])=[CH:37][C:36]=3[CH3:47])(=[O:32])=[O:31])[CH2:26][CH2:25]2)[N:20]=1>C(Cl)Cl.CCC[N+](CCC)(CCC)CCC.[O-][Ru](=O)(=O)=O>[CH3:41][C:40]1[CH:39]=[C:38]([N:42]([CH3:46])[C:43]([NH2:45])=[O:44])[CH:37]=[C:36]([CH3:47])[C:35]=1/[CH:34]=[CH:33]/[S:30]([N:27]1[CH2:28][CH2:29][C:21]2([N:20]=[C:19]([CH2:18][CH2:17][CH2:16][CH2:15][CH2:14][CH2:13][CH2:12][CH2:11][CH:10]=[O:9])[NH:23][C:22]2=[O:24])[CH2:25][CH2:26]1)(=[O:31])=[O:32]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
NMO (22.0 mg, 0.192 mmol), Molecular Sieves 4A (25.0 mg) and TPAP (0.700 mg, 0.00213 mmol) were added to a solution of 1-(4-{2-[2-(9-hydroxy-nonyl)-4-oxo-1,3,8-triaza-spiro[4.5]dec-1-ene-8-sulfonyl]-ethyl}-3,5-dimethyl-phenyl)-1-methyl-urea (24.0 mg, 0.0426 mmol) in CH2Cl2 (850 μl) at room temperature. The mixture was stirred at room temperature for one hour and then filtered through celite, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel chromatography to give 1-(3,5-dimethyl-4-{(E)-2-[4-oxo-2-(9-oxo-nonyl)-1,3,8-triaza-spiro[4.5]dec-1-ene-8-sulfonyl]-vinyl}-phenyl)-1-methyl-urea (17.0 mg, 71%).
Workup
- filtrationfiltered through celite
- concentrationthe filtrate was concentrated under reduced pressure
- customThe residue was purified by silica gel chromatography
Sources & evidence
- ORD record
- ord-17434fdee6c74413ac9e619b979308bb
- Source dataset
- uspto-grants-2015_10
- Patent number
- US09169254B2
Reaction notes
Loading…